Moderna chooses Denmark for clinical trials
Moderna chooses Denmark for clinical trials

Case

Unlocking innovation: Moderna chooses Denmark for clinical trials

Case

Unlocking innovation: Moderna chooses Denmark for clinical trials

Moderna is a fast-growing biotech company based in Boston, USA. Founded in 2010 with technology from MIT, Moderna uses the mRNA platform to develop new medicines. Moderna made its breakthrough with the development of one of the first COVID-19 vaccines. In addition to vaccine development, Moderna also focuses on oncology and rare diseases.

When

Over the past years, Invest in Denmark, in close collaboration with Trial Nation, Denmark’s national entry point for companies looking to conduct clinical trials, and Innovation Center Denmark in Boston, has established a close collaboration with Moderna, leading the company to choose Denmark for two vaccine studies within RSV and influenza.

"We chose to place these studies in Denmark due to easy access to patients in clinical research, as well as Denmark's reputation for its top-notch medical studies. The integral role of Invest in Denmark’s collaboration with the non-profit organization Trial Nation is also extremely efficient and helpful."

Catharina Maijgren Steffensson 

Medical Director Nordics, Moderna

a national entry point for life science companies

Invest in Denmark has had a strong focus on attracting clinical trials to Denmark since 2015. Through the collaboration with Trial Nation, companies interested in conducting clinical trials in Denmark can get free assistance with:

 

  • Feasibility studies within 5 days of enquiry

  • Contact to investigators through a national network of disease specific clinicians

  • Advise on framework conditions and regulatory processes

  • Insights on how to effectively leverage Danish Healthcare data, amongst the richest and most comprehensive in the world

  • Access a national structure covering clinical trials in medical devices

 “Our collaboration with Invest in Denmark is extremely valuable. Through their location at Danish representations, we are able to reach key decision makers in biopharma and medtech companies looking to Europe for clinical trials. Together, we enable companies to get easy access to world-class clinical research to Denmark.” 

Marianne Pilgaard 

CEO, Trial Nation

All the right conditions 

Denmark is an increasingly attractive location for businesses that depend on clinical trials. For many years, the Danish government has taken active steps to boost the life science industry by building on the already strong national healthcare system and world-class environment for business and science. This also includes a keen political focus on improving the framework conditions for conducting clinical trials in Denmark.

Continuous optimization of clinical trial processes and procedures, a highly-skilled workforce, and excellent hospitals and researchers make Denmark a very attractive place for international biopharma and medtech companies wanting to conduct clinical research and trials.

I’m delighted that Moderna has chosen Denmark for clinical trials. It is a testament to our competitive biopharma cluster as well as the Danish government’s consistent focus on improving framework conditions for conducting clinical trials and research.

Vanessa Vega Saenz 

Director, Invest in Denmark

get in touch

Want to explore doing clinical research in Denmark?

We provide free-of-charge confidential and tailor-made solutions for foreign companies looking to set up a new business in Denmark or expand an existing one. Please contact one of our experts here:  

Copenhagen

  • Sarina Lohmann

    Title: Special Advisor – Maritime and transport – Analysis & Partnerships

    Area: Copenhagen

    Phone: +4533920423

Berlin

Kolding

Silkeborg

Aarhus

Aalborg

Oslo

London

Paris

Munich

New-York

Toronto

Silicon-Valley

Tokyo

Bangalore

Taipei

Shanghai

Singapore